Literature DB >> 16501658

Biomedical research and mining of the poor: the need for their exclusion.

R R Kishore1.   

Abstract

Almost all ethical guidelines and legislative policies concerning biomedical research involving human subjects contain provisions about relevance of research for the participating populations, informed consent, adequate care for research induced injuries and several other safeguards but the poor continue to suffer. Globalization has further aggravated poor people's vulnerability by exposing them to international markets. Since the developing countries are abode of higher population of the poor they have become the unholy mines of this human ore for researchers. In this paper I examine various dimensions of poverty and analyze the international ethical responses in the area of biomedical research involving human subjects in order to determine their adequacy to protect the poor against exploitation and misuse and conclude that in view of the poor's inherent and extreme vulnerability and the failure of ethical pronouncements to protect them from misuse and exploitation, they should be excluded from being enrolled as research subjects.

Entities:  

Mesh:

Year:  2006        PMID: 16501658     DOI: 10.1007/s11948-006-0017-8

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  4 in total

1.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  The goals of medicine. Setting new priorities.

Authors: 
Journal:  Hastings Cent Rep       Date:  1996 Nov-Dec       Impact factor: 2.683

3.  Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine.

Authors: 
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

4.  Commercialisation of genetic diagnostic services.

Authors:  R Hoedemaekers; H ten Have
Journal:  Med Health Care Philos       Date:  1998
  4 in total
  3 in total

1.  Conference summary: 'The responsible conduct of basic and clinical research'.

Authors:  Raymond E Spier
Journal:  Sci Eng Ethics       Date:  2006-01       Impact factor: 3.525

2.  How should you safely outsource pharmacovigilance to an Indian contract research organization?

Authors:  Brian Edwards
Journal:  Indian J Pharmacol       Date:  2008-02       Impact factor: 1.200

3.  Compensation of subjects for participation in biomedical research in resource - limited settings: a discussion of practices in Malawi.

Authors:  Wongani Nyangulu; Randy Mungwira; Nginanche Nampota; Osward Nyirenda; Lufina Tsirizani; Edson Mwinjiwa; Titus Divala
Journal:  BMC Med Ethics       Date:  2019-11-14       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.